Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Conditions: Cytomegalovirus Retinitis; Ganciclovir Eye Drops Intervention: Drug: 2% Ganciclovir Eye Drops Sponsor: Tianjin Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT
Condition: The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation Intervention: Drug: Letermovir Sponsor: Institute of Hematology & Blood Diseases Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
Condition: Congenital Cytomegalovirus Infection Intervention: Sponsor: Central Hospital, Nancy, France Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm Interventions: Procedure: Biospecimen Collection; Drug: Letermovir Sponsor: Children's Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 3, 2023 Category: Research Source Type: clinical trials
